Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
D000230:Adenocarcinoma / Q000628:therapy; D000818:Animals; D000951:Antigens, Neoplasm; D003208:Concanavalin A / Q000627:therapeutic use*; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy; D008325:Mammary Neoplasms, Experimental / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D008937:Mitomycins / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000628:therapy; D014734:Vibrio cholerae / Q000201:enzymology
D000951:Antigens, Neoplasm; D008937:Mitomycins; D003208:Concanavalin A; D008748:Methylcholanthrene; D009439:Neuraminidase